Processa Pharmaceuticals, Inc.
corporate_fare Company Profile
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) is a publicly traded company in the Life Sciences sector. Wiseek monitors PCSA SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Shareholders to Vote on 200,000 Share Increase for Incentive Plan Amidst Going Concern
- Processa Pharmaceuticals Issues Going Concern Warning Amidst Significant Cash Burn and Urgent Capital Needs
- Processa Pharmaceuticals Amends 10-K to Detail $1.4M Capital Raises and Executive Compensation
- Chief Development Officer Transitions to Part-Time Role, No Longer Executive Officer
- Major Investor Increases Stake in Processa Pharmaceuticals with $200K Purchase
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$13.56M
Diluted EPS
-$10.36
Op. Cash Flow
-$11.39M
Operating Income
-$13.99M
Cash & Equivalents
$5.54M
Debt / Equity
0.00×
Shares Outstanding
2.57M sh
Source: 10-K · filed 2026-04-30 · accession 0001493152-26-020731
show_chartPrice Chart
Loading chart...
feed PCSA - Latest Insights
PCSA
Jun 18, 2026, 4:05 PM EDT
Price at Filing:
$2.12
Real-time Price:
$2.93
Change:
+$0.810 (+38%)
Market Cap:
$8.11M
PCSA
May 07, 2026, 4:18 PM EDT
Price at Filing:
$2.87
Real-time Price:
$2.93
Change:
+$0.060 (+2%)
Market Cap:
$8.11M
PCSA
Apr 30, 2026, 5:14 PM EDT
Price at Filing:
$2.70
Real-time Price:
$2.93
Change:
+$0.230 (+9%)
Market Cap:
$8.11M
PCSA
Apr 30, 2026, 5:11 PM EDT
Price at Filing:
$2.70
Real-time Price:
$2.93
Change:
+$0.230 (+9%)
Market Cap:
$8.11M
PCSA
Feb 23, 2026, 11:00 AM EST
Price at Filing:
$2.09
Real-time Price:
$2.93
Change:
+$0.8433 (+40%)
Market Cap:
$8.11M
PCSA
Feb 19, 2026, 4:05 PM EST
Price at Filing:
$2.28
Real-time Price:
$2.93
Change:
+$0.650 (+29%)
Market Cap:
$8.11M
PCSA
Jan 07, 2026, 8:30 AM EST
Price at Filing:
$3.58
Real-time Price:
$2.93
Change:
-$0.6537 (-18%)
Market Cap:
$8.11M